Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.3K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-time digital monitoring of continuous bladder irrigation: clinical evaluation of a sensor-based system for hematuria and catheter-associated events.

Frontiers in digital health·2025
Same author

Long-term follow-up of "three horse shoe-like incision (3-HSI) holmium laser enucleation of the prostate: outcomes and efficacy of a novel en-bloc technique for anatomic transurethral prostatectomy".

BMC urology·2025
Same author

Multivariable regression analysis of perioperative parameters for a novel pulsed solid-state Thulium: YAG laser with high peak power versus Holmium: YAG laser in prostate enucleation.

World journal of urology·2025
Same author

Holmium laser enucleation of the prostate and strictures: long-term outcomes, stricture characteristics, and risk factors.

World journal of urology·2025
Same author

PD-L1 expression assessment in Angiosarcoma improves with artificial intelligence support.

Journal of pathology informatics·2025
Same author

Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Related Experiment Video

Updated: Mar 5, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K

[Primary prostatic sarcoma - a rare malignancy].

A Herlemann1, D Horst2, M D'Anastasi3

  • 1Urologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, Marchioninistraße 15, 81377, München, Deutschland. Annika.Herlemann@med.uni-muenchen.de.

Der Urologe. Ausg. A
|March 29, 2017
PubMed
Summary
This summary is machine-generated.

Primary prostatic sarcomas are rare malignancies, often presenting with urinary symptoms and normal prostate-specific antigen (PSA) levels. Diagnosis requires imaging and histology, with treatment involving multimodal approaches due to aggressive nature and poor prognosis.

Keywords:
HistopathologyLeiomyosarcomaRhabdomyosarcomaStromal sarcomaTumor, mesenchymal

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.6K

Related Experiment Videos

Last Updated: Mar 5, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.6K

Area of Science:

  • Oncology
  • Urology

Background:

  • Primary prostatic sarcomas are rare, constituting less than 1% of all prostate cancers.
  • These tumors often present with lower urinary tract symptoms due to bladder outlet obstruction.

Observation:

  • Prostate-specific antigen (PSA) levels are typically normal in patients with primary prostatic sarcoma.
  • Computed tomography (CT) or magnetic resonance imaging (MRI) of the pelvis and abdomen are crucial for diagnosis and staging.

Findings:

  • Histological confirmation is essential for differentiating primary prostatic sarcoma from sarcomatoid prostate cancer or benign spindle cell tumors.
  • Primary prostatic sarcomas are frequently aggressive, necessitating multimodal treatment strategies.

Implications:

  • Multimodal treatment, including surgery and adjuvant therapies (radiation/chemotherapy), is required for primary prostatic sarcoma.
  • High risk of local recurrence and poor long-term prognosis underscore the need for early detection and aggressive management.